Gracure Pharmaceuticals Limited Meloxicam Export Data — India (DGFT 2022–2026)

Name: Gracure Pharmaceuticals Limited Meloxicam Export Records India — #8 Exporter, 40 Shipments, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Meloxicam

India Pharmaceutical Trade Intelligence

$199.4M277 Suppliers100 CountriesHS 30049066

ExportsIndia → UNITED STATES86.3%India → SERBIA3.0%

ImportsUNITED STATES → India$1.1M GERMANY → India$19.9K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Gracure Pharmaceuticals Limited — Meloxicam Exporter #8 | $1.0M Trade Value | TransData Nexus | TransData Nexus

Gracure Pharmaceuticals Limited — Meloxicam Exporter Profile

Indian Pharmaceutical Exporter · #8 for Meloxicam · $1.0M export value · DGFT Verified

Gracure Pharmaceuticals Limited is the #8 Indian exporter of Meloxicam with $1.0M in export value and 40 verified shipments. Gracure Pharmaceuticals Limited holds a 0.5% market share in Meloxicam exports across 1 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.

Gracure Pharmaceuticals Limited — Meloxicam Export Profile: Buyers & Destinations

Gracure Pharmaceuticals Limited Meloxicam export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Meloxicam?

Country	Value	Shipments	Share
UNITED STATES	$53.4M	1,067	77.6%
AUSTRALIA	$3.1M	255	4.5%
VIETNAM	$2.3M	46	3.3%
NIGERIA	$1.9M	39	2.8%

Who Are the Top Buyers of Meloxicam from India?

Buyer	Country	Value	Orders
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$25.3M	533
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$6.8M	165
UNICHEM PHARMACEUTICALS (USA) INC.	UNITED STATES	$4.5M	90
UNICHEM PHARMACEUTICALS (USA) INC..	UNITED STATES	$1.9M	39
CIPLA USA INC UPS SUPPLY CHAIN SOL	UNITED STATES	$1.5M	92
UNICHEM PHARMACEUTICALS USA INC	UNITED STATES	$1.0M	32
GENERIC PARTNERS PTY LTD	AUSTRALIA	$843.8K	32
NICHE GENERICS LTD.	IRELAND	$643.3K	20
SANDOZ PTY LTD,	AUSTRALIA	$479.5K	37
ALLEGENS COMPANY LIMITED	VIETNAM	$400.0K	8

India's Meloxicam is purchased by 566 buyers worldwide. The top buyer is CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), followed by EVERSANA LIFE SCIENCE SERVICES and UNICHEM PHARMACEUTICALS (USA) INC..

How Does Gracure Pharmaceuticals Limited Compare to Nearest Meloxicam Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	LUPIN LIMITED	$1.5M	30	1	$50.0K
7	AUROBINDO PHARMA LTD	$1.1M	127	13	$8.4K
8	GRACURE PHARMACEUTICALS LIMITED ★	$1.0M	40	1	$26.0K
9	CADILA HEALTHCARE LIMITED	$1.0M	30	3	$33.3K
6	MACLEODS PHARMACEUTICALS LTD	$850.0K	17	3	$50.0K

Gracure Pharmaceuticals Limited ranks #8 among 277 Indian Meloxicam exporters. Average shipment value of $26.0K compared to the market average of $227.2K. The closest competitors by value are LUPIN LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Meloxicam Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	583	17.7%
JNPT/ NHAVA SHEVA SEA	374	11.3%
SAHAR AIR	370	11.2%
SAHAR AIR CARGO ACC (INBOM4)	276	8.4%
JNPT	242	7.3%
NHAVA SHEVA	147	4.5%
MUNDRA SEA	137	4.2%
Bombay Air	117	3.5%

Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Meloxicam Exports

Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)

For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.

Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.

Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Meloxicam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 566+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Meloxicam

Meloxicam

Gracure Pharmaceuticals Limited — Meloxicam Exporter Profile

Gracure Pharmaceuticals Limited — Meloxicam Export Profile: Buyers & Destinations

Where Does India Export Meloxicam?

Who Are the Top Buyers of Meloxicam from India?

What Is India's Total Meloxicam Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Meloxicam Exports?

How Does Gracure Pharmaceuticals Limited Compare to Other Indian Meloxicam Exporters?

Regulatory Requirements: Exporting Meloxicam to Key Markets

United States — FDA

Australia — TGA

How Does Gracure Pharmaceuticals Limited Compare to Nearest Meloxicam Exporters?

Which Indian Ports Ship Meloxicam Exports?

What Other Analgesics & Antipyretics Products Does Gracure Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Meloxicam Exports

Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Gracure Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Meloxicam Export Data from Gracure Pharmaceuticals Limited

Meloxicam Stats

Company Overview

Top Products by Gracure Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source